Control of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Wang, Jinhai ^a   Roderiquez, Gregory ^a   Norcross, Michael A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CD86 ANTIGEN; CHEMOKINE; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; ARTICLE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; MONOCYTE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANTIGENS, CD274; ANTIGENS, CD86; CELLS, CULTURED; CHEMOKINES; CYTOKINES; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MACROPHAGES; MONOCYTES; SRC-FAMILY KINASES; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION, GENETIC;

EID: 84866064403     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00606     Document Type: Article

References (45)

1. Lowy, F. D. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532 (1998).
2. David, M. Z., Mennella, C., Mansour, M., Boyle-Vavra, S. & Daum, R. S. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. J Clin Microbiol. 46, 3222-3227 (2008).
3. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity. 11, 443-451 (1999). (Pubitemid 29504199)
4. Takeuchi, O., Hoshino, K. & Akira, S. Cutting edge: TLR2-deficient and MyD88- deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 165, 5392-5396 (2000).
5. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11, 115-122 (1999). (Pubitemid 29359962)
6. Leendertse, M. et al. TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J. Immunol. 180, 4865-4874 (2008).
7. Santos-Sierra, S. et al. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J. 28, 2018-2027 (2009).
8. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
9. Moran, G. J. et al.Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355, 666-674 (2006).
10. Grundmann, H., Aires-de-Sousa, M., Boyce, J. & Tiemersma, E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 368, 874-885 (2006). (Pubitemid 44308640)
11. Klevens, R. M. et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 298, 1763-1771 (2007). (Pubitemid 47598444)
12. Castaldo, E. T. & Yang, E. Y. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem. Am. Surg. 73, 684-687 (2007). (Pubitemid 351396623)
13. Miller, L. S. & Cho, J. S. Immunity against Staphylococcus aureus cutaneous infections. Nat. Rev. Immunol. 10, (2011).
14. Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948-958 (2005). (Pubitemid 43078158)
15. Houghton, A. M., Hartzell, W. O., Robbins, C. S., Gomis-Ruth, F. X. & Shapiro, S. D. Macrophage elastase kills bacteria within murine macrophages. Nature. 460, 637-641 (2009).
16. Docke, W. D. et al. Monocyte deactivation in septic patients: restoration by IFNgamma treatment. Nat. Med. 3, 678-681 (1997).
17. Docke, W. D. & Volk, H. D. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood. 96, 218-223 (2000).
18. Lekkou, A., Karakantza, M.,Mouzaki, A.,Kalfarentzos, F.& Gogos, C. A. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin. Diagn. Lab Immunol. 11, 161-167 (2004). (Pubitemid 38090671)
19. Monneret, G. et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 32, 1175-1183 (2006). (Pubitemid 44232412)
20. Fadok, V. A.,Warner, M. L., Bratton, D. L. & Henson, P. M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161, 6250-6257 (1998). (Pubitemid 28535999)
21. Greenberg, M. E. et al. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203, 2613-2625 (2006). (Pubitemid 44833338)
22. Nilsen, N. J. et al. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 84, 280-291 (2008). (Pubitemid 351960303)
23. Wang, J. E. et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68, 3965-3970 (2000). (Pubitemid 30434548)
24. Hayes, M. P.,Wang, J. & Norcross, M. A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood. 86, 646-650 (1995).
25. Boniface, K., Blom, B., Liu, Y. J. & deWaal, M. R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol. Rev. 226, 132-146 (2008).
26. Corinti, S., Albanesi, C., la, S. A., Pastore, S. & Girolomoni, G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol. 166, 4312-4318 (2001). (Pubitemid 32233711)
27. Abe, R. et al. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg. Res. 147, 1-8 (2008). (Pubitemid 351626078)
28. Fumeaux, T. & Pugin, J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am. J. Respir. Crit Care Med. 166, 1475-1482 (2002). (Pubitemid 35387298)
29. Reith, W. & Mach, B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev Immunol. 19, 331-373 (2001). (Pubitemid 32368039)
30. Wang, J., Roderiquez, G., Jones, T., McPhie, P. & Norcross, M. A. Control of in vitro immune responses by regulatory oligodeoxynucleotides through inhibition of pIII promoter directed expression of MHC class II transactivator in human primary monocytes. J. Immunol. 179, 45-52 (2007). (Pubitemid 46986516)
31. Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210, 171-186 (2006).
32. Guan, E. et al. T cell leukemia-associated human Notch/translocation- associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J. Exp. Med. 183, 2025-2032 (1996). (Pubitemid 26158895)
33. Wang, J. et al. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J. Immunol. 167, 289-295 (2001). (Pubitemid 32567791)
34. Keir, M. E., Butte, M. J., Freeman, G. J. & Sharpe, A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704 (2008). (Pubitemid 351600389)
35. Withers, D. R. et al. T cell-dependent survival of CD201 and CD20- plasma cells in human secondary lymphoid tissue. Blood. 109, 4856-4864 (2007). (Pubitemid 46827782)
36. Chau, T. A. et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat. Med. 15, 641-648 (2009).
37. Frodermann, V. et al. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect. Dis. 204, 253-262 (2011).
38. Wolfle, S. J. et al. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J Immunol. 41, 413-424 (2011).
39. McGeachy, M. J. & Cua, D. J. Th17 cell differentiation: the long and winding road. Immunity. 28, 445-453 (2008). (Pubitemid 351467042)
40. Annunziato, F. & Romagnani, S. Do studies in humans better depict Th17 cells? Blood. (2009).
41. Lyakh, L., Trinchieri, G., Provezza, L., Carra, G. & Gerosa, F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 226, 112-131 (2008).
42. Ivanov, I. I., Zhou, L. & Littman, D. R. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 19, 409-417 (2007). (Pubitemid 351274050)
43. Kudva, A. et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol. 186, 1666-1674 (2011).
44. Picard, C. et al.Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore). 89, 403-425 (2010).
45. von, B. H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 321, 691-696 (2008).